Articles with public access mandates - Morag ParkLearn more
OverallCIHRFRQSNIHNSERCGenome CanadaCCSDoDSusan G. KomenCancer Research UKEuropean CommissionWellcomeOICRNSFSwedish Research CouncilBreast Cancer Now, UKV Foundation, USAHHMIPCCMRCNIHRFRQNTFNRSFWOAcademy of FinlandSFIWorldwide Cancer Research, UKGovernment of SpainBMBFGovernment of ItalyCPRITMelanoma Research Alliance
Not available anywhere: 9
Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity
G Deblois, JA Hall, MC Perry, J Laganiere, M Ghahremani, M Park, ...
Cancer research 69 (15), 6149-6157, 2009
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptor
MM Frigault, MA Naujokas, M Park
Journal of cellular physiology 214 (3), 694-705, 2008
Mandates: Canadian Institutes of Health Research
MS/MS‐based strategies for proteomic profiling of invasive cell structures
S Havrylov, M Park
Proteomics 15 (2-3), 272-286, 2015
Mandates: Canadian Institutes of Health Research
Laser capture microdissection as a tool to study tumor stroma
NR Bertos, M Park
The Tumor Microenvironment: Methods and Protocols, 13-25, 2016
Mandates: Fonds de recherche du Québec - Santé
HER2Δ16 engages ENPP1 to promote an immune-cold microenvironment in breast cancer
SS Attalla, J Boucher, H Proud, T Taifour, D Zuo, V Sanguin-Gendreau, ...
Cancer immunology research 11 (9), 1184-1202, 2023
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research, Fonds de …
Inferring Copy Number from Triple-Negative Breast Cancer Patient Derived Xenograft scRNAseq Data Using scCNA
E Kuzmin, J Monlong, C Martinez, H Kuasne, CL Kleinman, J Ragoussis, ...
Mapping Genetic Interactions, 285-303, 2021
Mandates: Wellcome Trust
Covalent protein modification as a mechanism for dynamic recruitment of specific interactors
NR Bertos, V Sangwan, XJ Yang, M Park
Post-Translational Modifications in Health and Disease, 259-279, 2011
Mandates: Canadian Institutes of Health Research
Tumors and Their Microenvironments
NR Bertos, M Park
Cancer Systems Biology, 261-281, 2010
Mandates: Canadian Institutes of Health Research
Role of Stroma in Disease Progression
NR Bertos, M Park
Experimental and Clinical Metastasis: A Comprehensive Review, 129-147, 2013
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Available somewhere: 138
Stromal gene expression predicts clinical outcome in breast cancer
G Finak, N Bertos, F Pepin, S Sadekova, M Souleimanova, H Zhao, ...
Nature medicine 14 (5), 518-527, 2008
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ...
Cancer cell 22 (1), 21-35, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Pten in stromal fibroblasts suppresses mammary epithelial tumours
AJ Trimboli, CZ Cantemir-Stone, F Li, JA Wallace, A Merchant, N Creasap, ...
Nature 461 (7267), 1084-1091, 2009
Mandates: US National Institutes of Health
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
T Gruosso, M Gigoux, VSK Manem, N Bertos, D Zuo, I Perlitch, SMI Saleh, ...
The Journal of clinical investigation 129 (4), 1785-1800, 2019
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé
miR-378∗ mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway
LJ Eichner, MC Perry, CR Dufour, N Bertos, M Park, J St-Pierre, V Giguère
Cell metabolism 12 (4), 352-361, 2010
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
A Bronisz, J Godlewski, JA Wallace, AS Merchant, MO Nowicki, ...
Nature cell biology 14 (2), 159-167, 2012
Mandates: US National Institutes of Health
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
MG Ponzo, R Lesurf, S Petkiewicz, FP O'Malley, D Pinnaduwage, ...
Proceedings of the National Academy of Sciences 106 (31), 12903-12908, 2009
Mandates: Canadian Institutes of Health Research
Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Y Du, H Yamaguchi, Y Wei, JL Hsu, HL Wang, YH Hsu, WC Lin, WH Yu, ...
Nature medicine 22 (2), 194-201, 2016
Mandates: US National Institutes of Health, Susan G. Komen
ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties
AAN Rose, MG Annis, Z Dong, F Pepin, M Hallett, M Park, PM Siegel
PloS one 5 (8), e12093, 2010
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Regulation of endocytosis via the oxygen-sensing pathway
Y Wang, O Roche, MS Yan, G Finak, AJ Evans, JL Metcalf, BE Hast, ...
Nature medicine 15 (3), 319-324, 2009
Mandates: Canadian Institutes of Health Research
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
AAN Rose, AA Grosset, Z Dong, C Russo, PA MacDonald, NR Bertos, ...
Clinical cancer research 16 (7), 2147-2156, 2010
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Publication and funding information is determined automatically by a computer program